Insmed to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 13:01 pm UTC| Business
BRIDGEWATER, N.J., Jan. 04, 2017 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported that the company will participate at...
Provident Financial Services, Inc. Schedules Fourth Quarter Earnings Conference Call
Jan 04, 2017 13:01 pm UTC| Business
ISELIN, N.J., Jan. 04, 2017 -- Provident Financial Services, Inc. (NYSE:PFS) announced that it expects to release financial results for the quarter and year ended December 31, 2016 on Friday January 27, 2017 at...
Jan 04, 2017 13:01 pm UTC| Business
-Evan Tzanis promoted to Senior Vice President, Clinical Development and Clinical Operations -Jeanne Jew promoted to Senior Vice President, Business Development BOSTON, Jan. 04, 2017 -- Paratek Pharmaceuticals,...
Chimerix to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 04, 2017 13:01 pm UTC| Business
DURHAM, N.C., Jan. 04, 2017 -- Chimerix (NASDAQ:CMRX), a biopharmaceutical company discovering and developing medicines that improve outcomes for immunocompromised patients, today announced that M. Michelle Berrey,...
Rob Deakin, CEO of Icon Media Holdings, Inc., Featured in Exclusive Interview with SmallCapVoice.com
Jan 04, 2017 13:00 pm UTC| Business
AUSTIN, Texas, Jan. 04, 2017 -- SmallCapVoice.com, Inc. (SCV) and Icon Media Holdings, Inc. (OTC PINK:ICNM) announced today that, Rob Deakin, CEO of Icon Media Holdings, Inc., called in to SmallCapVoice.com to discuss...
Jan 04, 2017 13:00 pm UTC| Business
TouchView TDDI, Natural ID Combine for Best-in-Class Human Interface SAN JOSE, Calif., Jan. 04, 2017 -- Synaptics Incorporated (NASDAQ:SYNA), the leading developer of human interface solutions, today announced Huawei...
Jan 04, 2017 13:00 pm UTC| Business
WARREN, N.J., Jan. 04, 2017 -- Bellerophon Therapeutics,Inc. (Nasdaq:BLPH), a clinical-stage biotherapeutics company, today announced that it received confirmation from the U.S. Food and Drug Administration (FDA) of the...